Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).

Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, Emad Y.

Joint Bone Spine. 2013 Jan;80(1):38-43. doi: 10.1016/j.jbspin.2012.03.008. Epub 2012 May 9.

PMID:
22575064
2.

Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.

Peckham H, Cambridge G, Bourke L, Sen D, Radziszewska A, Leandro M, Ioannou Y.

Arthritis Rheumatol. 2017 Jul;69(7):1387-1395. doi: 10.1002/art.40117. Epub 2017 Jun 5.

PMID:
28380667
3.

Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.

Spârchez M, Miu N, Bolba C, Iancu M, Spârchez Z, Rednic S.

Clin Rheumatol. 2016 Mar;35(3):601-7. doi: 10.1007/s10067-015-2971-5. Epub 2015 May 21.

PMID:
25994613
4.

Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).

Lipinska J, Lipinska S, Kasielski M, Smolewska E.

Clin Rheumatol. 2016 Nov;35(11):2699-2706. Epub 2016 Jul 25.

PMID:
27457366
5.

Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Gupta R, Thabah MM, Vaidya B, Gupta S, Lodha R, Kabra SK.

Indian J Pediatr. 2010 Jan;77(1):41-4. doi: 10.1007/s12098-010-0006-4. Epub 2010 Feb 5.

PMID:
20135267
6.

Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Habib HM, Mosaad YM, Youssef HM.

Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057.

PMID:
18991100
7.

Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.

Moore TL, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):740-6. Epub 2014 Jul 17.

PMID:
25068682
8.
9.

[Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].

Zhang L, Ru J, Jie X, Che G, Jin X, Li X.

Zhonghua Er Ke Za Zhi. 2015 Dec;53(12):948-51. Chinese.

PMID:
26887552
10.

Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.

van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B, van Venrooij WJ.

J Rheumatol. 2003 Apr;30(4):825-8.

PMID:
12672206
11.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
12.

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

Berntson L, Nordal E, Fasth A, Aalto K, Herlin T, Nielsen S, Rygg M, Zak M, Rönnelid J; Nordic Study Group of Pediatric Rheumatology (NoSPeR).

Pediatr Rheumatol Online J. 2014 Jun 11;12:22. doi: 10.1186/1546-0096-12-22. eCollection 2014.

13.

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.

Kuna AT, Lamot L, Miler M, Harjacek M, Simundic AM, Vrkic N.

Clin Chem Lab Med. 2009;47(12):1525-30. doi: 10.1515/CCLM.2009.288.

PMID:
19842993
14.

Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.

Kwok JS, Hui KH, Lee TL, Wong W, Lau YL, Wong RW, Kim DL, Jones BM.

Scand J Rheumatol. 2005 Sep-Oct;34(5):359-66.

PMID:
16234183
15.

Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.

Pang SY, Liu HY, Huang YJ, Liu YF, Dai YM, Zeng P, Zeng HS.

Genet Mol Res. 2016 May 13;15(2). doi: 10.4238/gmr.15028641.

16.

Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.

Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM.

Arthritis Rheum. 2005 Jan;52(1):239-46.

17.

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis.

Gilliam BE, Reed MR, Chauhan AK, Dehlendorf AB, Moore TL.

Pediatr Rheumatol Online J. 2011 Mar 25;9:8. doi: 10.1186/1546-0096-9-8.

18.

Anticitrullinated protein antibodies and radiological progression in juvenile idiopathic arthritis.

Lipinska J, Brózik H, Stanczyk J, Smolewska E.

J Rheumatol. 2012 May;39(5):1078-87. doi: 10.3899/jrheum.110879. Epub 2012 Mar 1.

PMID:
22382337
19.
20.

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.

Ann Rheum Dis. 2006 Apr;65(4):453-8. Epub 2005 Sep 21.

Supplemental Content

Support Center